Click for best price
Biosimilar of Remicade Market Size, Share 2024
| Market size in 2023 |
US$ 282010 million
|
Forecast Market size by 2030 |
US$ 473740 million
|
| Growth Rate |
CAGR of 7.6% |
Number of Pages |
136 Pages |
The global Biosimilar of Remicade market was valued at US$ 282010 million in 2023 and is projected to reach US$ 473740 million by 2030, at a CAGR of 7.6% during the forecast period.
This research report provides a comprehensive analysis of the Biosimilar of Remicade market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Biosimilar of Remicade market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Biosimilar of Remicade, challenges faced by the industry, and potential opportunities for market players.
The global Biosimilar of Remicade market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Biosimilar of Remicade market presents opportunities for various stakeholders, including Tumor, Diabetes. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Biosimilar of Remicade market. Additionally, the growing consumer demand present avenues for market expansion.
The market for biosimilars of Remicade is driven by the increasing adoption of biosimilar therapies and the need for affordable treatment options for autoimmune diseases. The market's growth is also influenced by the presence of well-established regulatory pathways for biosimilar approval and the entry of multiple biosimilar manufacturers into the market.
Key Features:
The research report on the Biosimilar of Remicade market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Biosimilar of Remicade market.
Market Overview: The report provides a comprehensive overview of the Biosimilar of Remicade market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Monoclonal Antibodies, Interferon), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Biosimilar of Remicade market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Biosimilar of Remicade market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Biosimilar of Remicade market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Biosimilar of Remicade market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Biosimilar of Remicade market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Biosimilar of Remicade market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Biosimilar of Remicade, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Biosimilar of Remicade market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Biosimilar of Remicade market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Monoclonal Antibodies
Interferon
Erythropoietin
Insulin
Vaccines
Other
Market segment by Application
Tumor
Diabetes
Cardiovascular
Hemophilia
Other
Global Biosimilar of Remicade Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Roche
Amgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
3sbio
Changchun High Tech
CP Guojian
Biotech
Gelgen
Innovent
Dong Bao
Ganlee
United Laboratories
Outline of Major Chapters:
Chapter 1: Introduces the definition of Biosimilar of Remicade, market overview.
Chapter 2: Global Biosimilar of Remicade market size in revenue.
Chapter 3: Detailed analysis of Biosimilar of Remicade company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Biosimilar of Remicade in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Biosimilar of Remicade Market, Global Outlook and Forecast 2024-2030 |
| Market size in 2023 |
US$ 282010 million
|
| Forecast Market size by 2030 |
US$ 473740 million
|
| Growth Rate |
CAGR of 7.6% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
136 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Biosimilar of Remicade Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biosimilar of Remicade Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biosimilar of Remicade Overall Market Size
2.1 Global Biosimilar of Remicade Market Size: 2023 VS 2030
2.2 Global Biosimilar of Remicade Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Biosimilar of Remicade Players in Global Market
3.2 Top Global Biosimilar of Remicade Companies Ranked by Revenue
3.3 Global Biosimilar of Remicade Revenue by Companies
3.4 Top 3 and Top 5 Biosimilar of Remicade Companies in Global Market, by Revenue in 2023
3.5 Global Companies Biosimilar of Remicade Product Type
3.6 Tier 1, Tier 2 and Tier 3 Biosimilar of Remicade Players in Global Market
3.6.1 List of Global Tier 1 Biosimilar of Remicade Companies
3.6.2 List of Global Tier 2 and Tier 3 Biosimilar of Remicade Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Biosimilar of Remicade Market Size Markets, 2023 & 2030
4.1.2 Monoclonal Antibodies
4.1.3 Interferon
4.1.4 Erythropoietin
4.1.5 Insulin
4.1.6 Vaccines
4.1.7 Other
4.2 By Type - Global Biosimilar of Remicade Revenue & Forecasts
4.2.1 By Type - Global Biosimilar of Remicade Revenue, 2019-2024
4.2.2 By Type - Global Biosimilar of Remicade Revenue, 2025-2030
4.2.3 By Type - Global Biosimilar of Remicade Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Biosimilar of Remicade Market Size, 2023 & 2030
5.1.2 Tumor
5.1.3 Diabetes
5.1.4 Cardiovascular
5.1.5 Hemophilia
5.1.6 Other
5.2 By Application - Global Biosimilar of Remicade Revenue & Forecasts
5.2.1 By Application - Global Biosimilar of Remicade Revenue, 2019-2024
5.2.2 By Application - Global Biosimilar of Remicade Revenue, 2025-2030
5.2.3 By Application - Global Biosimilar of Remicade Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Biosimilar of Remicade Market Size, 2023 & 2030
6.2 By Region - Global Biosimilar of Remicade Revenue & Forecasts
6.2.1 By Region - Global Biosimilar of Remicade Revenue, 2019-2024
6.2.2 By Region - Global Biosimilar of Remicade Revenue, 2025-2030
6.2.3 By Region - Global Biosimilar of Remicade Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Biosimilar of Remicade Revenue, 2019-2030
6.3.2 US Biosimilar of Remicade Market Size, 2019-2030
6.3.3 Canada Biosimilar of Remicade Market Size, 2019-2030
6.3.4 Mexico Biosimilar of Remicade Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Biosimilar of Remicade Revenue, 2019-2030
6.4.2 Germany Biosimilar of Remicade Market Size, 2019-2030
6.4.3 France Biosimilar of Remicade Market Size, 2019-2030
6.4.4 U.K. Biosimilar of Remicade Market Size, 2019-2030
6.4.5 Italy Biosimilar of Remicade Market Size, 2019-2030
6.4.6 Russia Biosimilar of Remicade Market Size, 2019-2030
6.4.7 Nordic Countries Biosimilar of Remicade Market Size, 2019-2030
6.4.8 Benelux Biosimilar of Remicade Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Biosimilar of Remicade Revenue, 2019-2030
6.5.2 China Biosimilar of Remicade Market Size, 2019-2030
6.5.3 Japan Biosimilar of Remicade Market Size, 2019-2030
6.5.4 South Korea Biosimilar of Remicade Market Size, 2019-2030
6.5.5 Southeast Asia Biosimilar of Remicade Market Size, 2019-2030
6.5.6 India Biosimilar of Remicade Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Biosimilar of Remicade Revenue, 2019-2030
6.6.2 Brazil Biosimilar of Remicade Market Size, 2019-2030
6.6.3 Argentina Biosimilar of Remicade Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Biosimilar of Remicade Revenue, 2019-2030
6.7.2 Turkey Biosimilar of Remicade Market Size, 2019-2030
6.7.3 Israel Biosimilar of Remicade Market Size, 2019-2030
6.7.4 Saudi Arabia Biosimilar of Remicade Market Size, 2019-2030
6.7.5 UAE Biosimilar of Remicade Market Size, 2019-2030
7 Biosimilar of Remicade Companies Profiles
7.1 Roche
7.1.1 Roche Company Summary
7.1.2 Roche Business Overview
7.1.3 Roche Biosimilar of Remicade Major Product Offerings
7.1.4 Roche Biosimilar of Remicade Revenue in Global Market (2019-2024)
7.1.5 Roche Key News & Latest Developments
7.2 Amgen
7.2.1 Amgen Company Summary
7.2.2 Amgen Business Overview
7.2.3 Amgen Biosimilar of Remicade Major Product Offerings
7.2.4 Amgen Biosimilar of Remicade Revenue in Global Market (2019-2024)
7.2.5 Amgen Key News & Latest Developments
7.3 AbbVie
7.3.1 AbbVie Company Summary
7.3.2 AbbVie Business Overview
7.3.3 AbbVie Biosimilar of Remicade Major Product Offerings
7.3.4 AbbVie Biosimilar of Remicade Revenue in Global Market (2019-2024)
7.3.5 AbbVie Key News & Latest Developments
7.4 Sanofi-Aventis
7.4.1 Sanofi-Aventis Company Summary
7.4.2 Sanofi-Aventis Business Overview
7.4.3 Sanofi-Aventis Biosimilar of Remicade Major Product Offerings
7.4.4 Sanofi-Aventis Biosimilar of Remicade Revenue in Global Market (2019-2024)
7.4.5 Sanofi-Aventis Key News & Latest Developments
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Company Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Biosimilar of Remicade Major Product Offerings
7.5.4 Johnson & Johnson Biosimilar of Remicade Revenue in Global Market (2019-2024)
7.5.5 Johnson & Johnson Key News & Latest Developments
7.6 Pfizer
7.6.1 Pfizer Company Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Biosimilar of Remicade Major Product Offerings
7.6.4 Pfizer Biosimilar of Remicade Revenue in Global Market (2019-2024)
7.6.5 Pfizer Key News & Latest Developments
7.7 Novo Nordisk
7.7.1 Novo Nordisk Company Summary
7.7.2 Novo Nordisk Business Overview
7.7.3 Novo Nordisk Biosimilar of Remicade Major Product Offerings
7.7.4 Novo Nordisk Biosimilar of Remicade Revenue in Global Market (2019-2024)
7.7.5 Novo Nordisk Key News & Latest Developments
7.8 Eli Lilly
7.8.1 Eli Lilly Company Summary
7.8.2 Eli Lilly Business Overview
7.8.3 Eli Lilly Biosimilar of Remicade Major Product Offerings
7.8.4 Eli Lilly Biosimilar of Remicade Revenue in Global Market (2019-2024)
7.8.5 Eli Lilly Key News & Latest Developments
7.9 Novartis
7.9.1 Novartis Company Summary
7.9.2 Novartis Business Overview
7.9.3 Novartis Biosimilar of Remicade Major Product Offerings
7.9.4 Novartis Biosimilar of Remicade Revenue in Global Market (2019-2024)
7.9.5 Novartis Key News & Latest Developments
7.10 Merck
7.10.1 Merck Company Summary
7.10.2 Merck Business Overview
7.10.3 Merck Biosimilar of Remicade Major Product Offerings
7.10.4 Merck Biosimilar of Remicade Revenue in Global Market (2019-2024)
7.10.5 Merck Key News & Latest Developments
7.11 3sbio
7.11.1 3sbio Company Summary
7.11.2 3sbio Business Overview
7.11.3 3sbio Biosimilar of Remicade Major Product Offerings
7.11.4 3sbio Biosimilar of Remicade Revenue in Global Market (2019-2024)
7.11.5 3sbio Key News & Latest Developments
7.12 Changchun High Tech
7.12.1 Changchun High Tech Company Summary
7.12.2 Changchun High Tech Business Overview
7.12.3 Changchun High Tech Biosimilar of Remicade Major Product Offerings
7.12.4 Changchun High Tech Biosimilar of Remicade Revenue in Global Market (2019-2024)
7.12.5 Changchun High Tech Key News & Latest Developments
7.13 CP Guojian
7.13.1 CP Guojian Company Summary
7.13.2 CP Guojian Business Overview
7.13.3 CP Guojian Biosimilar of Remicade Major Product Offerings
7.13.4 CP Guojian Biosimilar of Remicade Revenue in Global Market (2019-2024)
7.13.5 CP Guojian Key News & Latest Developments
7.14 Biotech
7.14.1 Biotech Company Summary
7.14.2 Biotech Business Overview
7.14.3 Biotech Biosimilar of Remicade Major Product Offerings
7.14.4 Biotech Biosimilar of Remicade Revenue in Global Market (2019-2024)
7.14.5 Biotech Key News & Latest Developments
7.15 Gelgen
7.15.1 Gelgen Company Summary
7.15.2 Gelgen Business Overview
7.15.3 Gelgen Biosimilar of Remicade Major Product Offerings
7.15.4 Gelgen Biosimilar of Remicade Revenue in Global Market (2019-2024)
7.15.5 Gelgen Key News & Latest Developments
7.16 Innovent
7.16.1 Innovent Company Summary
7.16.2 Innovent Business Overview
7.16.3 Innovent Biosimilar of Remicade Major Product Offerings
7.16.4 Innovent Biosimilar of Remicade Revenue in Global Market (2019-2024)
7.16.5 Innovent Key News & Latest Developments
7.17 Dong Bao
7.17.1 Dong Bao Company Summary
7.17.2 Dong Bao Business Overview
7.17.3 Dong Bao Biosimilar of Remicade Major Product Offerings
7.17.4 Dong Bao Biosimilar of Remicade Revenue in Global Market (2019-2024)
7.17.5 Dong Bao Key News & Latest Developments
7.18 Ganlee
7.18.1 Ganlee Company Summary
7.18.2 Ganlee Business Overview
7.18.3 Ganlee Biosimilar of Remicade Major Product Offerings
7.18.4 Ganlee Biosimilar of Remicade Revenue in Global Market (2019-2024)
7.18.5 Ganlee Key News & Latest Developments
7.19 United Laboratories
7.19.1 United Laboratories Company Summary
7.19.2 United Laboratories Business Overview
7.19.3 United Laboratories Biosimilar of Remicade Major Product Offerings
7.19.4 United Laboratories Biosimilar of Remicade Revenue in Global Market (2019-2024)
7.19.5 United Laboratories Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Biosimilar of Remicade Market Opportunities & Trends in Global Market
Table 2. Biosimilar of Remicade Market Drivers in Global Market
Table 3. Biosimilar of Remicade Market Restraints in Global Market
Table 4. Key Players of Biosimilar of Remicade in Global Market
Table 5. Top Biosimilar of Remicade Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Biosimilar of Remicade Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Biosimilar of Remicade Revenue Share by Companies, 2019-2024
Table 8. Global Companies Biosimilar of Remicade Product Type
Table 9. List of Global Tier 1 Biosimilar of Remicade Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Biosimilar of Remicade Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Biosimilar of Remicade Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Biosimilar of Remicade Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Biosimilar of Remicade Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Biosimilar of Remicade Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Biosimilar of Remicade Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Biosimilar of Remicade Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Biosimilar of Remicade Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Biosimilar of Remicade Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Biosimilar of Remicade Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Biosimilar of Remicade Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Biosimilar of Remicade Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Biosimilar of Remicade Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Biosimilar of Remicade Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Biosimilar of Remicade Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Biosimilar of Remicade Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Biosimilar of Remicade Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Biosimilar of Remicade Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Biosimilar of Remicade Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Biosimilar of Remicade Revenue, (US$, Mn), 2025-2030
Table 30. Roche Company Summary
Table 31. Roche Biosimilar of Remicade Product Offerings
Table 32. Roche Biosimilar of Remicade Revenue (US$, Mn) & (2019-2024)
Table 33. Roche Key News & Latest Developments
Table 34. Amgen Company Summary
Table 35. Amgen Biosimilar of Remicade Product Offerings
Table 36. Amgen Biosimilar of Remicade Revenue (US$, Mn) & (2019-2024)
Table 37. Amgen Key News & Latest Developments
Table 38. AbbVie Company Summary
Table 39. AbbVie Biosimilar of Remicade Product Offerings
Table 40. AbbVie Biosimilar of Remicade Revenue (US$, Mn) & (2019-2024)
Table 41. AbbVie Key News & Latest Developments
Table 42. Sanofi-Aventis Company Summary
Table 43. Sanofi-Aventis Biosimilar of Remicade Product Offerings
Table 44. Sanofi-Aventis Biosimilar of Remicade Revenue (US$, Mn) & (2019-2024)
Table 45. Sanofi-Aventis Key News & Latest Developments
Table 46. Johnson & Johnson Company Summary
Table 47. Johnson & Johnson Biosimilar of Remicade Product Offerings
Table 48. Johnson & Johnson Biosimilar of Remicade Revenue (US$, Mn) & (2019-2024)
Table 49. Johnson & Johnson Key News & Latest Developments
Table 50. Pfizer Company Summary
Table 51. Pfizer Biosimilar of Remicade Product Offerings
Table 52. Pfizer Biosimilar of Remicade Revenue (US$, Mn) & (2019-2024)
Table 53. Pfizer Key News & Latest Developments
Table 54. Novo Nordisk Company Summary
Table 55. Novo Nordisk Biosimilar of Remicade Product Offerings
Table 56. Novo Nordisk Biosimilar of Remicade Revenue (US$, Mn) & (2019-2024)
Table 57. Novo Nordisk Key News & Latest Developments
Table 58. Eli Lilly Company Summary
Table 59. Eli Lilly Biosimilar of Remicade Product Offerings
Table 60. Eli Lilly Biosimilar of Remicade Revenue (US$, Mn) & (2019-2024)
Table 61. Eli Lilly Key News & Latest Developments
Table 62. Novartis Company Summary
Table 63. Novartis Biosimilar of Remicade Product Offerings
Table 64. Novartis Biosimilar of Remicade Revenue (US$, Mn) & (2019-2024)
Table 65. Novartis Key News & Latest Developments
Table 66. Merck Company Summary
Table 67. Merck Biosimilar of Remicade Product Offerings
Table 68. Merck Biosimilar of Remicade Revenue (US$, Mn) & (2019-2024)
Table 69. Merck Key News & Latest Developments
Table 70. 3sbio Company Summary
Table 71. 3sbio Biosimilar of Remicade Product Offerings
Table 72. 3sbio Biosimilar of Remicade Revenue (US$, Mn) & (2019-2024)
Table 73. 3sbio Key News & Latest Developments
Table 74. Changchun High Tech Company Summary
Table 75. Changchun High Tech Biosimilar of Remicade Product Offerings
Table 76. Changchun High Tech Biosimilar of Remicade Revenue (US$, Mn) & (2019-2024)
Table 77. Changchun High Tech Key News & Latest Developments
Table 78. CP Guojian Company Summary
Table 79. CP Guojian Biosimilar of Remicade Product Offerings
Table 80. CP Guojian Biosimilar of Remicade Revenue (US$, Mn) & (2019-2024)
Table 81. CP Guojian Key News & Latest Developments
Table 82. Biotech Company Summary
Table 83. Biotech Biosimilar of Remicade Product Offerings
Table 84. Biotech Biosimilar of Remicade Revenue (US$, Mn) & (2019-2024)
Table 85. Biotech Key News & Latest Developments
Table 86. Gelgen Company Summary
Table 87. Gelgen Biosimilar of Remicade Product Offerings
Table 88. Gelgen Biosimilar of Remicade Revenue (US$, Mn) & (2019-2024)
Table 89. Gelgen Key News & Latest Developments
Table 90. Innovent Company Summary
Table 91. Innovent Biosimilar of Remicade Product Offerings
Table 92. Innovent Biosimilar of Remicade Revenue (US$, Mn) & (2019-2024)
Table 93. Innovent Key News & Latest Developments
Table 94. Dong Bao Company Summary
Table 95. Dong Bao Biosimilar of Remicade Product Offerings
Table 96. Dong Bao Biosimilar of Remicade Revenue (US$, Mn) & (2019-2024)
Table 97. Dong Bao Key News & Latest Developments
Table 98. Ganlee Company Summary
Table 99. Ganlee Biosimilar of Remicade Product Offerings
Table 100. Ganlee Biosimilar of Remicade Revenue (US$, Mn) & (2019-2024)
Table 101. Ganlee Key News & Latest Developments
Table 102. United Laboratories Company Summary
Table 103. United Laboratories Biosimilar of Remicade Product Offerings
Table 104. United Laboratories Biosimilar of Remicade Revenue (US$, Mn) & (2019-2024)
Table 105. United Laboratories Key News & Latest Developments
List of Figures
Figure 1. Biosimilar of Remicade Segment by Type in 2023
Figure 2. Biosimilar of Remicade Segment by Application in 2023
Figure 3. Global Biosimilar of Remicade Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Biosimilar of Remicade Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Biosimilar of Remicade Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Biosimilar of Remicade Revenue in 2023
Figure 8. By Type - Global Biosimilar of Remicade Revenue Market Share, 2019-2030
Figure 9. By Application - Global Biosimilar of Remicade Revenue Market Share, 2019-2030
Figure 10. By Type - Global Biosimilar of Remicade Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Biosimilar of Remicade Revenue Market Share, 2019-2030
Figure 12. By Application - Global Biosimilar of Remicade Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Biosimilar of Remicade Revenue Market Share, 2019-2030
Figure 14. By Region - Global Biosimilar of Remicade Revenue Market Share, 2019-2030
Figure 15. By Country - North America Biosimilar of Remicade Revenue Market Share, 2019-2030
Figure 16. US Biosimilar of Remicade Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Biosimilar of Remicade Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Biosimilar of Remicade Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Biosimilar of Remicade Revenue Market Share, 2019-2030
Figure 20. Germany Biosimilar of Remicade Revenue, (US$, Mn), 2019-2030
Figure 21. France Biosimilar of Remicade Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Biosimilar of Remicade Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Biosimilar of Remicade Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Biosimilar of Remicade Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Biosimilar of Remicade Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Biosimilar of Remicade Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Biosimilar of Remicade Revenue Market Share, 2019-2030
Figure 28. China Biosimilar of Remicade Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Biosimilar of Remicade Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Biosimilar of Remicade Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Biosimilar of Remicade Revenue, (US$, Mn), 2019-2030
Figure 32. India Biosimilar of Remicade Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Biosimilar of Remicade Revenue Market Share, 2019-2030
Figure 34. Brazil Biosimilar of Remicade Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Biosimilar of Remicade Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Biosimilar of Remicade Revenue Market Share, 2019-2030
Figure 37. Turkey Biosimilar of Remicade Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Biosimilar of Remicade Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Biosimilar of Remicade Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Biosimilar of Remicade Revenue, (US$, Mn), 2019-2030
Figure 41. Roche Biosimilar of Remicade Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Amgen Biosimilar of Remicade Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. AbbVie Biosimilar of Remicade Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Sanofi-Aventis Biosimilar of Remicade Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Johnson & Johnson Biosimilar of Remicade Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Pfizer Biosimilar of Remicade Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Novo Nordisk Biosimilar of Remicade Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Eli Lilly Biosimilar of Remicade Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Novartis Biosimilar of Remicade Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Merck Biosimilar of Remicade Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. 3sbio Biosimilar of Remicade Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 52. Changchun High Tech Biosimilar of Remicade Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 53. CP Guojian Biosimilar of Remicade Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 54. Biotech Biosimilar of Remicade Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 55. Gelgen Biosimilar of Remicade Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 56. Innovent Biosimilar of Remicade Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 57. Dong Bao Biosimilar of Remicade Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 58. Ganlee Biosimilar of Remicade Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 59. United Laboratories Biosimilar of Remicade Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
